6 Articles
6 Articles
Terumo Neuro receives US FDA approval for carotid stent system - Interventional News
Terumo Neuro has announced that its carotid stent system has received premarket approval (PMA) from the US Food and Drug Administration (FDA). This milestone marks the first dual-layer micromesh carotid stent approved in the USA, offering physicians a clinically proven option to improve patient outcomes in carotid artery disease treatment, as per a Terumo Neuro press release. The company’s carotid stent system is indicated for the treatment of c…
Terumo Neuro’s Carotid Stent System Receives FDA Approval - Endovascular Today
April 15, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid stent system has received premarket approval from the FDA for the treatment of carotid artery disease. As stated in the press release, Terumo Neuro’s carotid stent system is indicated for the treatment of carotid artery stenosis in patients at increased risk for adverse events after carotid endarterectomy. The d…
Terumo Neuro Receives FDA Approval For Carotid Stent System - Medical Device News Magazine
This milestone marks the first dual-layer micromesh carotid stent approved in the United States, offering physicians a clinically proven option to improve patient outcomes in carotid artery disease treatment reports Terumo Neuro.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage